| Literature DB >> 25797885 |
E M Symonds1, M M Cook1, S M McQuaig2, R M Ulrich1, R O Schenck1, J O Lukasik3, E S Van Vleet1, M Breitbart1.
Abstract
To preserve environmental and human health, improved treatment processes are needed to reduce nutrients, microbes, and emerging chemical contaminants from domestic wastewater prior to discharge into the environment. Electrocoagulation (EC) treatment is increasingly used to treat industrial wastewater; however, this technology has not yet been thoroughly assessed for its potential to reduce concentrations of nutrients, a variety of microbial surrogates, and personal care products found in domestic wastewater. This investigation's objective was to determine the efficiency of a benchtop EC unit with aluminum sacrificial electrodes to reduce concentrations of the aforementioned biological and chemical pollutants from raw and tertiary-treated domestic wastewater. EC treatment resulted in significant reductions (p < 0.05, α = 0.05) in phosphate, all microbial surrogates, and several personal care products from raw and tertiary-treated domestic wastewater. When wastewater was augmented with microbial surrogates representing bacterial, viral, and protozoan pathogens to measure the extent of reduction, EC treatment resulted in up to 7-log10 reduction of microbial surrogates. Future pilot and full-scale investigations are needed to optimize EC treatment for the following: reducing nitrogen species, personal care products, and energy consumption; elucidating the mechanisms behind microbial reductions; and performing life cycle analyses to determine the appropriateness of implementation.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25797885 PMCID: PMC4369739 DOI: 10.1038/srep09380
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Mean +/− standard deviation of nutrient concentrations before and after EC treatment of raw wastewater and tertiary-treated wastewater with the benchtop unit. A negative t-statistic signifies an increase in nutrient concentrations after EC treatment. When a two-tailed student's t-test (t) or Wilcoxon Rank Sum test (S) revealed a positive, significant difference (α = 0.05) between pre- and post- EC treatment concentrations, the mean percent reduction was calculated
| Mean concentration +/− standard deviation (μM) | |||||
|---|---|---|---|---|---|
| Wastewater Sample | Nutrient | Pre-EC treatment | Post-EC treatment | Two-tailed student's t-test results | % Mean reduction |
| Raw | Nitrate + Nitrite | 11.20 +/− 0.79 | 10.63 +/− 0.31 | t = 1.36, p = 0.2218 | N/A |
| Nitrite | 0.52 +/− 0.07 | 0.33 +/− 0.06 | t = 3.83, p = 0.0087 | 64.48 | |
| Ammonium | 1349.34 +/− 10.88 | 1155.76 +/− 63.67 | t = 5.99, p = 0.0079 | 14.35 | |
| Phosphate | 62.76 +/− 20.17 | 2.65 +/− 0.42 | t = 19.93, p = 0.0003 | 95.79 | |
| Tertiary-treated | Nitrate + Nitrite | 2.88 +/− 0.22 | 1.49 +/− 0.38 | t = 6.34, p = 0.0007 | 48.35 |
| Nitrite | 0.11 +/− 0.03 | 0.41 +/− 0.02 | t = −15.87, p < 0.0001 | N/A | |
| Ammonium | 3.08 +/− 0.19 | 4.78 +/− 0.29 | t = −9.74, p < 0.0001 | N/A | |
| Phosphate | 3.95 +/− 0.20 | 0.15 +/− 0.02 | t = 37.87, p < 0.0001 | 96.33 | |
Mean +/− standard deviation (n = 4 unless indicated otherwise; n = 2 and n = 3) of bacteria and virus concentrations, two-tailed student's t-test (t) or Wilcoxon Rank Sum test (S) results, and mean percent reduction from domestic wastewater before and after EC treatment. Analyte concentrations are described as less than the process limit of detection (
| Mean concentration +/− standard deviation per milliliter | |||||||
|---|---|---|---|---|---|---|---|
| Wastewater Sample | Analyte | Pre-EC treatment | Post-EC treatment | Test statistic and p-value | % Mean reduction | ||
| Raw | 4.701 × 102 +/− 1.50 × 102 | <pLOD | S = 26.00, p = 0.0286 | >99.998 | |||
| Fecal coliform (cfu) | 1.95 × 102 +/− 2.29 × 102 | < pLOD | S = 26.00, p = 0.0286 | >99.995 | |||
| HPyVs (qPCR target) | 2.69 × 103 +/− 8.16 × 102 | < pLOD | S = 26.00, p = 0.0286 | >92.252 | |||
| PMMoV (qPCR target) | 5.47 × 104 +/− 1.64 × 104 | <pLOD | S = 26.00, p = 0.0286 | >99.800 | |||
| Tertiary- treated | 5.43 × 10−2 +/− 2.54 × 10−2 | <pLOD | S = 26.00, p = 0.0286 | >81.567 | |||
| Fecal coliform (cfu) | 7.40 × 101 +/− 4.05 × 101 | < pLOD | S = 26.00, p = 0.0286 | >99.986 | |||
| HPyVs (qPCR target) | <pLOD | < pLOD | N/A | N/A | |||
| PMMoV (qPCR target) | <pLOD | <pLOD | N/A | N/A | |||
| Spiked raw | 3.80 × 106 +/− 3.74 × 105 | 3.00 × 100 +/− 1.41 × 100
| S = 26.00, p = 0.0286 | >99.99996 | |||
| 1.25 × 108 +/− 1.56 × 107 | 2.15 × 100 +/− 4.12 × 100 | S = 26.00, p = 0.0286 | >99.999998 | ||||
| 1.37 × 106 +/− 1.40 × 105 | +BPLOQ | S = 26.00, p = 0.0286 | >99.507 | ||||
| 1.15 × 106 +/− 1.72 × 105 | <pLOD | S = 26.00, p = 0.0286 | >99.913 | ||||
| Fecal coliform (cfu) | 1.22 × 106 +/− 2.61 × 105 | 8.13 × 10−1 +/− 9.10 × 10−1
| t = 9.33, p = 0.0026 | >99.99993 | |||
| HPyVs (qPCR target) | 6.29 × 105 +/− 2.00 × 105 | < pLOD | S = 26.00, p = 0.0286 | >99.967 | |||
| PMMoV (qPCR target) | 6.38 × 106 +/− 2.35 × 106 | <pLOD | S = 26.00, p = 0.0286 | >99.998 | |||
| MS2 bacteriophage (pfu) | 3.72 × 104 +/− 3.82 × 103 | <pLOD | S = 26.00, p = 0.0286 | >99.9997 | |||
| Spiked tertiary- treated | 3.60 × 106 +/− 3.69 × 105 | 7.45 × 102 +/− 6.43 × 102 | t = 20.23, p = 0.0003 | >99.989 | |||
| 1.44 × 106 +/− 1.03 × 105 | 5.67 × 101 +/− 7.03 × 101 | t = 27.88, p = 0.0001 | >99.996 | ||||
| 1.68 × 106 +/− 1.40 × 105 | +BPLOQ | S = 26.00, p = 0.0286 | >99.702 | ||||
| 1.56 × 106 +/− 1.04 × 105 | +BPLOQ | S = 26.00, p = 0.0286 | >99.872 | ||||
| Fecal coliform (cfu) | 1.47 × 106 +/− 6.24 × 104 | 3.38 × 101 +/− 4.59 × 101 | t = 47.05, p < 0.0001 | >99.998 | |||
| HPyVs (qPCR target) | 7.69 × 105 +/− 2.81 × 105 | < pLOD | S = 26.00, p = 0.0286 | >99.973 | |||
| PMMoV (qPCR target) | 1.24 × 107 +/− 6.26 × 106 | +BPLOQ | S = 26.00, p = 0.0286 | >99.998 | |||
| MS2 bacteriophage (pfu) | 2.98 × 104 +/− 5.34 × 103 | <pLOD | S = 26.00, p = 0.0286 | >99.9996 | |||
Mean +/− standard deviation of personal care product concentrations before and after EC treatment of raw and tertiary-treated wastewater with the benchtop unit (n = 4, unless otherwise noted). Any undetected analytes are listed as less than the reported process limit of detection (
| Raw wastewater | Tertiary-treated wastewater | |||||||
|---|---|---|---|---|---|---|---|---|
| Mean concentration +/− standard deviation (ng/L) | Mean concentration +/− standard deviation (ng/L) | |||||||
| Analyte | Pre-EC treatment | Post-EC treatmet | Test statistic and p-value | % Mean reduction | Pre-EC treatment | Post-EC treatment | Test statistic and p-value | % Mean reduction |
| Acetaminophen | 55750 +/− 28000E | 28000 +/− 4243E | S = 26.00, p = 0.0286 | 49.78 | <pLOD | <pLOD | N/A | N/A |
| Caffeine | 31250 +/− 3202E | 26250 +/− 4787E | S = 23.00, p = 0.1714 | N/A | <pLOD | 72 +/− 3 | N/A | N/A |
| Carbamazepine | 130 +/− 16 | 125 +/− 6 | S = 20.00, p = 0.6564 | N/A | 165 +/− 6 | 178 +/− 10 | N/A | N/A |
| DEET | 4075 +/− 263 | 3400 +/− 424E | t = 2.70, p = 0.0354 | 16.56 | 29 +/− 1 | 68 +/− 12 | N/A | N/A |
| Gemfibrozil | 2700 +/− 13 | 2350 +/− 82E | t = 4.58, p = 0.0038 | 12.96 | <pLOD | <pLOD | N/A | N/A |
| Ibuprofen | 12000 +/− 817E | 9950 +/− 900E | t = 3.37, p = 0.0150 | 17.08 | <pLOD | <pLOD | N/A | N/A |
| Iopromide | 4600 +/− 653* | 3325 +/− 619*, E | S = 26.00, p = 0.0286 | 24.77 | 505 +/− 31 | 350 +/− 26 | t = 7.67, p = 0.0003 | 31.00 |
| Meprobamate | 655 +/− 48 | 660 +/− 82E | t = 0.11, p = 0.9193 | N/A | 588 +/− 24E | 645 +/− 44E | N/A | N/A |
| Naproxen | 11250 +/− 500E | 11250 +/− 500E | S = 18.00, p = 1.0000 | N/A | <pLOD | <pLOD | N/A | N/A |
| Phenytoin | <pLOD | 130 +/− 0 (n = 2) | N/A | N/A | 183 +/− 15 | 208 +/−15 | N/A | N/A |
| Primidone | <pLOD | <pLOD | N/A | N/A | <pLOD* | <pLOD* | N/A | N/A |
| Salicylic Acid | 32500 +/− 5568 | 9425 +/− 961E | S = 26.00, p = 0.0286 | 71.00 | 61 (n = 1) | 78 +/−15 | N/A | N/A |
| Sulfamethoxazole | 1925 +/− 310 | 1700 +/− 548E | t = 0.72, p = 0.5013 | N/A | 24 +/− 5 | < RL | S = 26.00, p = 0.0286 | 58.76 |
| Thiabendazole | <pLOD | 15 +/− 1 | N/A | N/A | 20 +/− 1 | 18 +/− 1 | t = 3.00, p = 0.0240 | 10.00 |
| Triclocarban | 728 +/−200 | 113 +/− 75 | t = 5.77, p = 0.0012 | 84.54 | <pLOD | <pLOD | N/A | N/A |
| Triclosan | 1350 +/−238 | 248 +/− 89 | t = 8.68, p = 0.0001 | 81.67 | <pLOD | <pLOD | N/A | N/A |
| Trimethoprim | 488 +/− 54 | 508 +/− 48E | t = 0.56, p = 0.5986 | N/A | <pLOD | <pLOD | N/A | N/A |
| Warfarin | <pLOD | <pLOD | N/A | N/A | <pLOD | <pLOD | N/A | N/A |
Figure 1The benchtop electrocoagulation unit with nine aluminum blades arranged vertically in the unit chamber.
Electrical connections on the first, fifth, and ninth blades were connected to a 110-volt AC to DC power converter. A peristaltic pump re-circulated wastewater up through the unit chamber, into the post-treatment reservoir, and into the collection reservoir.